Similar Articles
351 Hepatocellular carcinoma: State of the art diagnostic imaging
352 Pain management in patients with hepatocellular carcinoma after transcatheter arterial chemoembolisation: A retrospective study
353 mRNA transcriptome profiling of human hepatocellular carcinoma cells HepG2 treated with Catharanthus roseus-silver nanoparticles
354 Adherence to guideline-directed hepatocellular carcinoma screening: A single-center US experience
355 Patients with hepatocellular carcinoma that die during the first year of liver transplantation have high blood sFasL concentrations
356 miR-124 is upregulated in diabetic mice and inhibits proliferation and promotes apoptosis of high-glucose-induced β-cells by targeting EZH2
357 Possible mechanisms associated with immune escape and apoptosis on anti-hepatocellular carcinoma effect of Mu Ji Fang granules
358 Systemic treatment for unresectable hepatocellular carcinoma
359 Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma
360 Predictors of early and late hepatocellular carcinoma recurrence
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA